We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Aneurysm wall enhancement, atherosclerotic proteins, and aneurysm size may be related in unruptured intracranial fusiform aneurysms.
- Authors
Peng, Fei; Niu, Hao; Feng, Xin; Liu, Lang; Xu, Peng; Zhang, Hong; Chen, Jigang; Tong, Xin; Xia, Jiaxiang; He, Xiaoxin; Xu, Boya; Chen, Xuge; Sui, Binbin; Duan, Yonghong; Zhao, Xingquan; Liu, Aihua
- Abstract
Objective: This cross-sectional study aimed to investigate the associations between aneurysm wall enhancement (AWE), atherosclerotic protein levels, and aneurysm size in unruptured intracranial fusiform aneurysms (IFAs). Methods: Patients with IFAs underwent high-resolution magnetic resonance imaging (HR-MRI) and atherosclerotic protein examinations from May 2015 to December 2021 were collected. A CRstalk (signal intensity [SI] of IFA wall/SI of pituitary stalk) > 0.60 was considered to indicate AWE. Atherosclerotic protein data was obtained from the peripheral blood. Aneurysmal characteristics included the maximal diameter of the cross-section (Dmax), location, type of IFA, presence of mural thrombus, and mural clots. Statistical analyses were performed with univariate analysis, logistic regression analysis, and Spearman's correlation coefficient. Results: Seventy-one IFAs from 71 patients were included in the study. Multivariate analysis revealed statin use (OR = 0.189, p = 0.026) and apolipoprotein B (Apo-B) level (OR = 6.019, p = 0.026) were the independent predictors of AWE in IFAs. In addition, statin use (OR = 0.813, p = 0.036) and Apo-B level (OR = 1.610, p = 0.003) were also the independent predictors of CRstalk. Additionally, we found that CRstalk and AWE were significantly positively associated with Dmax (rs = 0.409 and 0.349, respectively; p < 0.001 and p = 0.003, respectively). Conclusions: There may be correlations between AWE, atherosclerotic protein levels, and aneurysm size in patients with IFAs. Apo-B and statin use were independent predictors of AWE in IFAs, which have the potential to be new therapeutic targets for IFAs. Key Points: • There may be correlations between aneurysm wall enhancement, atherosclerotic protein levels in the peripheral blood, and aneurysm size in patients with intracranial fusiform aneurysms. • Apolipoprotein B and statin use were independent predictors of aneurysm wall enhancement in intracranial fusiform aneurysms.
- Subjects
INTRACRANIAL aneurysms; ANEURYSMS; APOLIPOPROTEIN B; LOGISTIC regression analysis; MAGNETIC resonance imaging
- Publication
European Radiology, 2023, Vol 33, Issue 7, p4918
- ISSN
0938-7994
- Publication type
Article
- DOI
10.1007/s00330-023-09456-9